MedPath

EFAMOL CALCIUM - CAP

EFAMOL CALCIUM - CAP

Discontinued
DIN Number

02163993

Drug Class

Human

Market Date

Jul 30, 1996

Company
HC

efamol research inc.

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02163993
AIG Number0427622001
Classification & Schedule
C
Drug Class
Human
S
Schedule
OTC
A
ATC Code
A11JC VITAMINS, OTHER COMBINATIONS
Product Specifications
Dosage FormCapsule
Route of AdministrationOral
AHFS Classification88:30.00*
Health Canada Classification

ACTIVE INGREDIENTS (4)

CALCIUM (CALCIUM CARBONATE)Active
Strength: 100 MG
Monograph: CALCIUM (CALCIUM CARBONATE)
CIS-LINOLEIC ACID (EVENING PRIMROSE OIL)Active
Strength: 255 MG
Monograph: CIS-LINOLEIC ACID (EVENING PRIMROSE OIL)
D-ALPHA TOCOPHERYL ACETATEActive
Strength: 13.6 UNIT
Monograph: D-ALPHA TOCOPHERYL ACETATE
GAMMA-LINOLENIC ACID (EVENING PRIMROSE OIL)Active
Strength: 30 MG
Monograph: GAMMA-LINOLENIC ACID (EVENING PRIMROSE OIL)

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.